Zhangzhou Pien Tze Huang Pharmaceutical Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
2,886
- Stock Symbol
-
600436
- Investments
-
1
- Share Price
-
$19.29
- (As of Friday Closing)
Zhangzhou Pien Tze Huang Pharmaceutical General Information
Description
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include tablets, hard capsules, granules, pills (water pills, honey pills), syrups, tinctures (including external use), ointments, lozenges, decoctions, Chinese herbal medicine slices (including direct oral slices) (clean preparation); production of candy products (candy), health food products; and production of beverages (solid beverages).
Contact Information
Website
www.zzpzh.comCorporate Office
- Shang Street
- Zhangzhou, Fujian 363000
- China
Corporate Office
- Shang Street
- Zhangzhou, Fujian 363000
- China
Zhangzhou Pien Tze Huang Pharmaceutical Stock Performance
As of 20-Nov-2026, Zhangzhou Pien Tze Huang Pharmaceutical’s stock price is $19.29. Its current market cap is $11.6B with 603M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.29 | $19.48 | $15.59 - $25.31 | $11.6B | 603M | 2.96M | $0.32 |
Zhangzhou Pien Tze Huang Pharmaceutical Financials Summary
As of 30-Sep-2026, Zhangzhou Pien Tze Huang Pharmaceutical has a trailing 12-month revenue of $1.15B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 10,538,609 | 14,593,766 | 17,519,708 | 20,380,346 |
| Revenue | 1,147,381 | 1,251,705 | 1,503,439 | 1,421,720 |
| EBITDA | 221,718 | 372,084 | 506,463 | 489,617 |
| Net Income | 191,061 | 300,172 | 414,887 | 395,392 |
| Total Assets | 2,642,517 | 2,509,760 | 2,402,660 | 2,409,561 |
| Total Debt | 152,444 | 151,809 | 157,302 | 164,544 |
Zhangzhou Pien Tze Huang Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Zhangzhou Pien Tze Huang Pharmaceutical Comparisons
Industry
Financing
Details
Zhangzhou Pien Tze Huang Pharmaceutical Competitors (1)
One of Zhangzhou Pien Tze Huang Pharmaceutical’s competitors is Yunnan Baiyao Group, a Corporation company based in Kunming, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Yunnan Baiyao Group | Corporation | Kunming, China |
Zhangzhou Pien Tze Huang Pharmaceutical Patents
Zhangzhou Pien Tze Huang Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4692082-A1 | Crystal form of 2,6-piperidinedione compound, and preparation method therefor and use thereof | Pending | 24-Mar-2023 | ||
| US-20260265239-A1 | Crystal form of 2,6-piperidinedione compound, and preparation method therefor and use thereof | Pending | 24-Mar-2023 | ||
| WO-2024199147-A1 | Crystal form of 2,6-piperidinedione compound, and preparation method therefor and use thereof | Inactive | 24-Mar-2023 | ||
| JP-2026512830-A | Crystalline form, manufacturing method, and use of 2,6-piperidinedione compounds | Active | 24-Mar-2023 | ||
| JP-7881081-B2 | Crystalline form, manufacturing method, and use of 2,6-piperidinedione compounds | Active | 24-Mar-2023 | A61P35/00 |
Zhangzhou Pien Tze Huang Pharmaceutical Signals
Zhangzhou Pien Tze Huang Pharmaceutical Acquisitions (1)
Zhangzhou Pien Tze Huang Pharmaceutical’s most recent deal was a Merger/Acquisition with Longhui Pharmaceutical for . The deal was made on 14-Jul-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Longhui Pharmaceutical | 14-Jul-2020 | Merger/Acquisition | Pharmaceuticals |
Zhangzhou Pien Tze Huang Pharmaceutical ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
30.01 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Zhangzhou Pien Tze Huang Pharmaceutical Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Zhangzhou Pien Tze Huang Investment Management | Zhangzhou, China | 2022 | |
| Longhui Pharmaceutical | Qiqihar, China | 2005 |
Zhangzhou Pien Tze Huang Pharmaceutical FAQs
-
When was Zhangzhou Pien Tze Huang Pharmaceutical founded?
Zhangzhou Pien Tze Huang Pharmaceutical was founded in 1999.
-
Where is Zhangzhou Pien Tze Huang Pharmaceutical headquartered?
Zhangzhou Pien Tze Huang Pharmaceutical is headquartered in Zhangzhou, China.
-
What is the size of Zhangzhou Pien Tze Huang Pharmaceutical?
Zhangzhou Pien Tze Huang Pharmaceutical has 2,886 total employees.
-
What industry is Zhangzhou Pien Tze Huang Pharmaceutical in?
Zhangzhou Pien Tze Huang Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Zhangzhou Pien Tze Huang Pharmaceutical a private or public company?
Zhangzhou Pien Tze Huang Pharmaceutical is a Public company.
-
What is Zhangzhou Pien Tze Huang Pharmaceutical’s stock symbol?
The ticker symbol for Zhangzhou Pien Tze Huang Pharmaceutical is 600436.
-
What is the current stock price of Zhangzhou Pien Tze Huang Pharmaceutical?
As of 20-Nov-2026 the stock price of Zhangzhou Pien Tze Huang Pharmaceutical is $19.29.
-
What is the current market cap of Zhangzhou Pien Tze Huang Pharmaceutical?
The current market capitalization of Zhangzhou Pien Tze Huang Pharmaceutical is $11.6B.
-
What is Zhangzhou Pien Tze Huang Pharmaceutical’s current revenue?
The trailing twelve month revenue for Zhangzhou Pien Tze Huang Pharmaceutical is $1.15B.
-
Who are Zhangzhou Pien Tze Huang Pharmaceutical’s competitors?
Yunnan Baiyao Group is a competitor of Zhangzhou Pien Tze Huang Pharmaceutical.
-
What is Zhangzhou Pien Tze Huang Pharmaceutical’s annual earnings per share (EPS)?
Zhangzhou Pien Tze Huang Pharmaceutical’s EPS for 12 months was $0.32.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process